Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis

References

1. Anuntagool N., Intachote P., Wuthiekanun V., White N. J., Sirisinha S. 1998; Lipopolysaccharide from nonvirulent Ara+ Burkholderia pseudomallei isolates is immunologically indistinguishable from lipopolysaccharide from virulent Ara− clinical isolates. Clin Diagn Lab Immunol 5:225–229
   [Google Scholar]
2. Ashdown L. R. 1992; Rapid differentiation of Pseudomonas pseudomallei from Pseudomonas cepacia. Lett Appl Microbiol 14:203–205 [CrossRef]
   [Google Scholar]
3. Atkins T., Prior R., Mack K., Russel P., Nelson M., Prior J., Oyston P. C., Dougan G., Titball R. W. 2002; Characterisation of an acapsular mutant of Burkholderia pseudomallei identified by signature tagged mutagenesis. J Med Microbiol 51:539–547
   [Google Scholar]
4. Brett P. J., Woods D. E. 1996; Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugates. Infect Immun 64:2824–2828
   [Google Scholar]
5. Bryan L. E., Wong S., Woods D. E., Dance D. A. B., Chaowagul W. 1994; Passive protection of the diabetic rat with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei. Can J Infect Dis 5:170–178
   [Google Scholar]
6. Chaowagul W. 2000; Recent advances in the treatment of severe melioidosis. Acta Trop 74:133–137 [CrossRef]
   [Google Scholar]
7. Chaowagul W., White N. J., Dance D. A. B., Wattanagoon Y., Naigowit P., Davis T. M. E., Looareesuwan S., Pitakwatchara N. 1989; Melioidosis : a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis 159:890–899 [CrossRef]
   [Google Scholar]
8. Chart H. 1994; LPS: isolation and characterisation. In Methods in Practical Laboratory Bacteriology pp 11–20 Edited by Chart H. Boca Raton, London, Tokyo: CRC Press;
   [Google Scholar]
9. Charuchaimontri C., Suputtamongkol Y., Nilakul C., Chaowagul W., Chetchotisakd P., Lertpatanasuwan N., Intaranongpai S., Brett P. E., Woods D. E. 1999; Anti-lipopolysaccharide II: an antibody protective against fatal melioidosis. Clin Infect Dis 29:813–818 [CrossRef]
   [Google Scholar]
10. Dance D. A. B. 2002; Melioidosis. Curr Opin Infect Dis 15:127–132 [CrossRef]
    [Google Scholar]
11. DeShazer D., Brett P. J., Woods D. E. 1998; The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence. Mol Microbiol 30:1081–1100 [CrossRef]
    [Google Scholar]
12. Harley V. S., Dance D. A. B., Drasar B. S., Tavey G. 1998; Effects of Burkholderia pseudomallei and other Burkholderia species on eukaryotic cells in tissue culture. Microbios 96:71–93
    [Google Scholar]
13. Ho M., Schollaardt T., Smith M. D., Perry M. B., Brett P. J., Chaowagul W., Bryan L. E. 1997; Specificity and functional activity of anti- Burkholderia pseudomallei polysaccharide antibody. Infect Immun 65:3648–3653
    [Google Scholar]
14. Johnson K. G., Perry M. B. 1975; Improved techniques for the preparation of bacterial polysaccharides. Can J Microbiol 22:29–34
    [Google Scholar]
15. Jones A. L., Beveridge T. J., Woods D. E. 1996; Intracellular survival of Burkholderia pseudomallei. Infect Immun 64:782–790
    [Google Scholar]
16. Jones S. M., Ellis J. F., Russell P., Griffin K. F., Oyston P. C. 2002; Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins. J Med Microbiol 52:1055–1062
    [Google Scholar]
17. Knirel Y. A., Paramonov N. A., Shashkov A. S., Kochetkov N. K., Yarullin R. G., Farber S. M., Efremenko V. I. 1992; Structure of the polysaccharide chains of Pseudomonas pseudomallei lipopolysaccharide. Carbohydr Res 233:185–193 [CrossRef]
    [Google Scholar]
18. Kourounakis L. H., Moller E. 1984; Adjuvants influence the immunoglobin subclass distribution of immune responses in vivo . Scand J Immunol 19:219–225
    [Google Scholar]
19. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685 [CrossRef]
    [Google Scholar]
20. Lee C. J., Banks S. D., Li J. P. 1991; Virulence, immunity and vaccine related to Streptococcus pneumoniae . Crit Rev Microbiol 18:89–111 [CrossRef]
    [Google Scholar]
21. Makela P. H. 2003; Conjugate vaccines – a breakthrough in vaccine development. Southeast Asian J Trop Med Public Health 34:249–253
    [Google Scholar]
22. Masihi K. N., Lange W., Brehmer W., Ribi E. 1986; Immunobiological activities of nontoxic lipid A: enhancement of nonspecific resistance in combination with trehalose dimycolate against viral infection and adjuvant effects. Int J Immunopharmacol 8:339–345 [CrossRef]
    [Google Scholar]
23. Perry M. B., MacLean L. L., Schollaardt T., Bryan L. E., Ho M. 1995; Structural characterization of the lipopolysaccharide O antigens of Burkholderia pseudomallei . Infect Immun 63:3348–3352
    [Google Scholar]
24. Pitt T. L., Aucken H., Dance D. A. B. 1992; Homogeneity of lipopolysaccharide antigens in Pseudomonas pseudomallei. J Infect 25:139–146
    [Google Scholar]
25. Reckseidler S. L., DeShazer D., Sokol P. A., Woods D. E. 2001; Detection of bacterial virulence genes by subtractive hybridisation: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Infect Immun 69:34–44 [CrossRef]
    [Google Scholar]
26. Russell P., Eley S. M., Green M. & 8 other authors; 1998; Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection. J Antimicrob Chemother 41:301–305 [CrossRef]
    [Google Scholar]
27. Stein K. E. 1992; Thymus-independent and thymus-dependent responses to polysaccharide antigens. J Infect Dis 165 (Suppl. 1):S49–S52 [CrossRef]
    [Google Scholar]
28. Steinmetz I., Rohde M., Brenneke B. 1995; Purification and characterisation of an exopolysaccharide of Burkholderia ( Pseudomonas ) pseudomallei . Infect Immun 63:3959–3965
    [Google Scholar]
29. van de Wijgert J. H., Verheul A. F., Snippe H., Check I. J., Hunter R. L. 1991; Immunogenicity of Streptococcus pneumoniae type 14 capsular polysaccharide: influence of carriers and adjuvants on isotype distribution. Infect Immun 59:2750–2757
    [Google Scholar]
30. Westphal O., Jann K. 1965; Bacterial lipopolysaccharides.Extraction with phenol-water and further applications of the procedure. Methods Carbohydr Chem 5:83–91
    [Google Scholar]
31. White N. J., Dance D. A. B., Chaowagul W. 1989; Halving the mortality of severe melioidosis by ceftazidime. Lancet 2:697–701
    [Google Scholar]
32. Woods D. E., Jones A. L., Hill P. J. 1993; Interaction of insulin with Pseudomonas pseudomallei . Infect Immun 61:1914–1919
    [Google Scholar]